Pregabalin and Streptococcal sepsis - a phase IV clinical study of FDA data

Summary:

Streptococcal sepsis is reported as a side effect among people who take Pregabalin (pregabalin), especially for people who are female, 60+ old, have been taking the drug for 1 - 2 years also take Euthyrox, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Streptococcal sepsis when taking Pregabalin. It is created by eHealthMe based on reports of 73,056 people who have side effects when taking Pregabalin from the FDA, and is updated regularly.

What is Pregabalin?

Pregabalin has active ingredients of pregabalin. It is often used in fibromyalgia. eHealthMe is studying from 74,069 Pregabalin users. Check the latest studies of Pregabalin.

What is Streptococcal sepsis?

Streptococcal sepsis (whole body inflammation by streptococcal) is found to be associated with 333 drugs and 359 conditions by eHealthMe. Check the latest studies of Streptococcal sepsis.

On Jul, 10, 2026

73,056 people reported to have side effects when taking Pregabalin.
Among them, 40 people (0.05%) have Streptococcal sepsis.

Could Pregabalin cause Streptococcal sepsis?

Among these 40 people:

How long have people been on Pregabalin when they have Streptococcal sepsis? *

What is the gender of people who have Streptococcal sepsis when taking Pregabalin? *

female: 87.5 %
male: 12.5 %

What is the age of people who have Streptococcal sepsis when taking Pregabalin? *

What are other drugs people take besides Pregabalin? *

What are other side effects people have besides Streptococcal sepsis? *

Fatigue (feeling of tiredness): 35 people, 87.50%
Pleural Effusion (water on the lungs): 32 people, 80.00%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 31 people, 77.50%
Pseudomonal Sepsis (pseudomonas infections are diseases caused by a bacterium from the genus pseudomonas): 31 people, 77.50%
Metastases To Lymph Nodes (cancer spreads to lymph node): 28 people, 70.00%
Metastases To Central Nervous System (cancer spreads to central nervous system): 26 people, 65.00%
Back Pain: 20 people, 50.00%
Nausea And Vomiting: 20 people, 50.00%
Nausea (feeling of having an urge to vomit): 20 people, 50.00%
Sepsis (a severe blood infection that can lead to organ failure and death): 10 people, 25.00%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 31 people, 77.50%
Paronychia (infection in the tissues adjacent to a nail on a finger or toe): 29 people, 72.50%
Skin Fissures (a crack in the skin): 29 people, 72.50%
Brain Oedema (excess accumulation of fluid in the intracellular or extracellular spaces of the brain): 22 people, 55.00%
Breast Cancer: 19 people, 47.50%
Cough: 6 people, 15.00%
Dyspnea (difficult or laboured breathing): 6 people, 15.00%
Gastrointestinal Disorder (functional problems of gastrointestinal tract): 5 people, 12.50%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 5 people, 12.50%
Metastatic Malignant Melanoma (spreadable cancer tumour of melanine): 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Pregabalin and have Streptococcal sepsis?

- Check whether Streptococcal sepsis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pregabalin:

Pregabalin (74,069 reports)

Browse all side effects of Pregabalin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Streptococcal sepsis:

Streptococcal sepsis (333 drugs)

Browse all the conditions that are associated with Streptococcal sepsis:

Streptococcal sepsis (359 conditions)

Related publications that referenced our studies

de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .
de Landaluce, L. O., Carbonell, P., Asensio, C., Escoda, N., López, P., & Laporte, J. R. , "Gabapentin and Pregabalin and Risk of Atrial Fibrillation in the Elderly: A Population-Based Cohort Study in an Electronic Prescription Database", Drug safety, 2018 Jan .
Bonnet U, Taazimi B, Grabbe HD, "Pregabalin-Related Hypertriglyceridemia", Psychosomatics, 2014 Nov .

How the study uses the data?

The study uses data from the FDA. It is based on pregabalin (the active ingredients of Pregabalin) and Pregabalin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.